Ensuring Safety in Public Health Programs RaPID Pharmacovigilance Program Safety First Paul Lalvani,...
6
Ensuring Safety in Public Health Programs ID R a ™ ID R a ™ RaPID Pharmacovigilance Program Safety First Paul Lalvani, Pharmacist, MBA, Executive Director O3i, RBM Board Meeting Nov 10-12 O 3i O 3i
-
Upload
carmella-bryan -
Category
Documents
-
view
219 -
download
3
Transcript of Ensuring Safety in Public Health Programs RaPID Pharmacovigilance Program Safety First Paul Lalvani,...
Ensuring Safety in Public Health Programs
I DR a
™
I DR a
™
RaPID Pharmacovigilance Program
Safety First
Paul Lalvani, Pharmacist, MBA, Executive Director O3i, RBM Board Meeting Nov 10-12
O3iO3i
0%5%
10%15%20%25%30%35%40%45%50%55%60%65%70%75%80%85%90%95%
100%
Botswana
Ghana
Sierra Leone
Sudan
Zambia
Zimbabwe
Recommended Target by UMC/WHO
Country
% of Target
AchievedIn collectingADR reports
Percent of Target Achieved in Collecting ADR Reports
Most countries are operating at 1% to 5% of target
RaPID Pilot
Africa for Africa
TANZANIA
BURUNDI
EQUATORIALGUINEA
ANGOLA
REP OFTHE
CONGOLibreville
Kananga
NdolaNacala
Dar es Salaam
Zanzibar
Mombasa
Beira
Kalemie
Antananarivo
Maputo
Lusaka
Bulawayo
Harare
Gaborone
Johannesburg
Durban
Port Elizabeth
MaseruMbabane
Cape Town
Luderitz
SOUTH AFRICAWalvis Bay
Windhoek
Namibe Menongue
Lobito
Malanje
Lilongwe
Mbeya
LakeTanganyika
Nyasa MALAWI
ZAMBIA
MOZAMBIQUE MADAGASCARZIMBABWE
BOTSWANA
SWAZILAND
Indian
Ocean
Indian
Ocean
LESOTHO
SOUTHAFRICA
Luanda
NAMIBIA
ANGOLA
Kinshasa
Brazzaville
Pointe-Noire
Toliara
Pretoria
Agadez
Zinder
NIGER
CHAD
Faya-Largeau
N' DjamenaMaiduguriKano
Abuja
Red Sea
SUDAN
ETHIOPIA
Khartoum
Al Fashir
Juba
Waw
Asmara
AddisAbaba
PortSudan
DJIBOUTI
ERITREA
UGANDASOMALIA
KENYADEMOCRATIC
REPUBLICOF THE CONGO
(ZAIRE)
CENTRALAFRICANREPUBLIC
RWANDAGABON
NIGERIA
Malabo
YaoundeBanguiCAMEROON
Djibouti
Berbera
MogadishuKisangani
Bujumbura
Nairobi
Kampala
Lake
LakeVictoria
Kigali
BecharTripoli
Al Jawt
Oran
Algiers Tunis
Cairo
Aswan
ConstantineRabat
Marrakech
Casablanca
El Aaiun
LombouctouNema
Nouakchott
Tamanrasset
TUNISIA
MOROCCO
WESTERNSAHARA
ALGERIA
MALI
LIBYA
NiameyBamako
Mediterranean Sea
EGYPT
AlexandriaBanghazi
BENIN
TOGOCOTEDTVOIRE
BURKINA
GUINEA
SENEGAL
GHANA
LIBERIA
Abidjan
AccraLoma
Porto-Novo
Ouagadougou
Lagos
MAURITANIA
Dakar
SIERRALEONE
GAMBIA
GUINEABISSAU
Monrovia
Freetown
BanjulTHE
Conakry
Bissau
Aggregate dataPreliminary QC
1
2
3
CLINIRX
MH UNIVO3iO3i
•Data entry•Causality assessment•Expectedness•Severity•QC
4
AfricaAsiaAmerica
Africa to Uppsala
5
Update global Vigiflow database
Safety
Benefits of Pharmacovigilance—beyond Safety
Quality Resistance
Improves
Quality of Care
Improves
Compliance
Reduces Drop Out Rates
